| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.56B | +28.7% |
| R&D Expense | $1.2M | +140.0% |
| SG&A Expense | $329.3M | +23.1% |
| Operating Income | $114.8M | +21.2% |
| Interest Expense | $32.1M | -1.2% |
| Pre-tax Income | $119.5M | +37.5% |
| Income Tax | -$3.4M | -1800.0% |
| Net Income | $86.2M | +14.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $455.0M | -41.4% |
| Accounts Receivable | $256.8M | +31.7% |
| Inventory | $3.4M | -29.2% |
| Current Assets | $1.15B | +16.3% |
| Total Assets | $3.39B | +32.6% |
| Current Liabilities | $704.4M | +162.5% |
| Long-term Debt | $1.77B | +0.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $388.3M | +41.0% |
| Capital Expenditures | $13.7M | +71.3% |
| Investing Cash Flow | -$301.9M | +41.6% |
| Financing Cash Flow | -$152.2M | +29.1% |
| Free Cash Flow | $374.6M | +40.1% |
| Total Liabilities |
| $2.52B |
| +21.5% |
| Stockholders' Equity | $653.3M | +88.1% |